论文部分内容阅读
氨苄青霉素(ABPC)是1961年开发的半合成青霉素,由于具有广泛的抗菌谱和优良的抗菌力而作为对许多感染症有效的抗生素长期使用。但是,ABPC给药途径只有注射剂及口服剂两种,由于疼痛及保护小儿血管等问题不便静注使用,肌注时也因四头肌短缩症而不能普遍使用,口服使用有腹泻的副作用,并且服药困难。为此,日本住友制药公司、京都药品工业公司新开发了小儿用氨
Ampicillin (ABPC), a semi-synthetic penicillin developed in 1961, has long been used as an effective antibiotic against many infectious diseases due to its broad antibacterial spectrum and excellent antibacterial properties. However, ABPC is administered only as an injection and as an oral. It is inconvenient for intravenous injection because of pain and protection of pediatric blood vessels. Intravenous injection can not be used universally due to tetanus shortening. Oral administration has the side effects of diarrhea, And medication is difficult. To this end, Japan’s Sumitomo Pharmaceuticals, Kyoto Pharmaceutical Industry Company has newly developed ammonia for children